Specialty Pharmaceuticals

Our products treat GI disorders

At Salix, we are committed to providing products that prevent or treat gastrointestinal (GI) disorders.

Salix Pharmaceuticals, headquartered in Raleigh, North Carolina, is a specialty pharmaceutical company committed to advancing the treatment of many chronic gastrointestinal disorders. For more than 20 years, we have licensed, developed, and marketed innovative products to provide healthcare professionals and patients with effective solutions for the management of some of the most chronic and debilitating conditions. Salix currently markets its product line through dedicated, specialty sales groups to U.S. healthcare providers in the areas of gastroenterology, hepatology, colorectal surgery, endocrinology, internal medicine, primary care, infectious disease, allergy/immunology, and pediatric urology.

GI disorder treatments

APRISO® (mesalamine) 0.375 g extended-release capsules

Prescribing Information

COLAZAL® (balsalazide disodium) 750 mg capsules

Prescribing Information

FULYZAQ® (crofelemer) 125 mg delayed-release tablets

Prescribing Information

GIAZO® (balsalazide disodium) 1.1 g tablets

Prescribing Information

METOZOLV® ODT (metoclopramide HCl) 5 mg orally disintegrating tablets

Prescribing Information, including BOXED WARNING

PEPCID® (famotidine) for oral suspension

Prescribing Information

RELISTOR® (methylnaltrexone bromide) subcutaneous injection

Prescribing Information

SOLESTA® (hyaluronic acid/dextranomer)

Prescribing Information

UCERIS® (budesonide) 9 mg extended-release tablets

Prescribing Information

UCERIS® (budesonide) 2 mg rectal foam

Prescribing Information

XIFAXAN® (rifaximin) 550 mg tablets

Prescribing Information

XIFAXAN® (rifaximin) 200 mg tablets

Prescribing Information

ZEGERID® (omeprazole/sodium bicarbonate) capsule and powder

Prescribing Information

Screening preps

MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) 100 g/7.5 g/2.691 g/1.015 g/5.9 g/4.7 g for oral solution

Prescribing Information

OSMOPREP® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) tablets

Prescribing Information, including BOXED WARNING

Other Salix products

ANUSOL-HC® (hydrocortisone) 2.5% cream

Prescribing Information

ANUSOL-HC® (hydrocortisone acetate) 25 mg suppository

Prescribing Information

PROCTOCORT® (hydrocortisone) 1% cream

Prescribing Information

PROCTOCORT® (hydrocortisone acetate) 30 mg suppository

Prescribing Information

AZASAN® (azathioprine) 75/100 mg tablets

Prescribing Information, including BOXED WARNING

CYCLOSET® (bromocriptine mesylate) 0.8 mg tablets

Prescribing Information

DIURIL® (chlorothiazide) 250 mg oral suspension

Prescribing Information

DEFLUX® (hyalouronic acid/dextranomer)

Prescribing Information

FENOGLIDE® (fenofibrate) 120 mg & 40 mg tablets

Prescribing Information

GLUMETZA® (metformin) 500 mg & 1000 mg tablets

Prescribing Information, including BOXED WARNING

RUCONEST® (C1 esterase inhibitor [recombinant]) for intravenous use

Prescribing Information

The information contained on this page is intended for US residents, healthcare providers, and pharmacists only.

SAL-US-0011 v1

Thank you for signing up. You will receive a confirmation email shortly./p>

Request Product Samples Order Product Literature Check out our latest Press Releases and News